Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: A prospective study in 2454 subsequent deliveries

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 72, Issue 2, 1997, Pages 137-140

  Poulain, P ^a   Betremieux, P ^a   Donnio, P Y ^a   Proudhon, J F ^a   Karege, G ^a   Giraud, J R ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Anti bioprophylaxy; Group B streptococci; Neonatal septicemia; Primary prevention

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; PATIENT SELECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

EID: 0031128043     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(96)02677-2     Document Type: Article

References (9)

1. [1] Gibbs RS, Hall RT, Yow MD, McCracken Jr GH, Nelson JD. Consensus: Perinatal prophylaxis for Group B streptococcal infection. Pediatr Infect Dis J 1992; 11: 179-183.
2. [2] Boyer KM, Gotoff SP. Prevention of early-onset Group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665-1669.
3. [3] Allen UD, Navas L, King SM. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. Can Med Assoc J 1993; 149: 1659-1665.
4. [4] Garland SM, Fliegner JR. Group B Streptococcus (GBS) and neonatal infections: the case of intrapartum chemoprophylaxis. Aust New Zealand Obstet Gynaecol 1991; 31: 119-122.
5. [5] Gibbs RS, McDuffie Jr RS, McNabb F, Fryer GE, Miyoshi T, Merenstein G. Neonatal group B streptococcal sepsis during 2 years of a universal screening program. Obstet Gynecol 1994; 84: 496-500.
6. [6] Jeffery HE, McIntosh EDG. Antepartum screening and non-selective intrapartum chemoprophylaxis for group B streptococcus. Aust New Zealand J Obstet Gynaecol 1994; 34: 14-19.
7. [7] Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. The active surveillance study group: Multistate case-control study of maternal risk factors for neonatal Group B streptococcal disease. Pediatr Infect Dis J 1994; 13: 623-629.
8. [8] Katz VL, Moos M-K, Cefalo RC, Thorp JM, Bowes WA, Wells SD. Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. Am J Obstet Gynecol 1994; 170: 521-526.
9. [9] Lejeune C, Jaby-Sergent MP, Floch-Tudal C. Infections néonatales précoces graves à streptocoque du groupe B. Etude multicentrique rétrospective de l'incidence et des facteurs de risque. J Gynecol Obstet Biol Reprod 1995; 24: 644-650.